You are here:Home-Chemical Inhibitors & Agonists-Proteasome/Ubiquitin-Deubiquitinase (DUB)-Usp22i-S02
Usp22i-S02

Chemical Structure : Usp22i-S02

CAS No.: 309735-96-4

Usp22i-S02

Catalog No.: PC-49546Not For Human Use, Lab Use Only.

Usp22i-S02 (Usp22 inhibitor S02) is a specific small-molecule inhibitor of the Foxp3-specific deubiquitinase USP22, down-regulates Foxp3 expression in Treg cells in a Usp22- but not Usp21-dependent manner.

Packing Price Stock Quantity
5 mg $198 In stock
10 mg $298 In stock
25 mg $488 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Usp22i-S02 (Usp22 inhibitor S02) is a specific small-molecule inhibitor of the Foxp3-specific deubiquitinase USP22, down-regulates Foxp3 expression in Treg cells in a Usp22- but not Usp21-dependent manner.
Usp22i-S02 stably binds not only to the hydrophobic residues but also to the charged and polar residues on the surface of the binding pocket of Usp22 protein, implying its potent efficacy in suppressing Usp22 catalytic functions.
Usp22i-S02 halts Usp22-mediated Foxp3 deubiquitination, Usp22i-S02 (10 ug/mL) down-regulates FoxP3 in a Usp22- but not Usp21-dependent manner in Usp22-null iTreg cells.
Usp22i-S02 has minimal effect on Foxp3 levels in murine Treg cells already lacking Usp22 both in vivo and in vitro.
Usp22i-S02 administration (20 mg/kg for 5 days) enhances antitumor immunity with low toxicity in mice, increases CD8+ T cell tumor infiltration, results in a Treg-specific phenotype in naïve mice with little effects on other immune cell types and tissue toxicity.
Usp22i-S02 (20 mg/kg for 3 days) showed marked tumor rejection in LLC1 tumor implantated mice.

Physicochemical Properties

M.Wt 338.414
Formula C22H18N4
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

11-(phenylamino)-7,8,9,10-tetrahydrobenzo[4,5]imidazo[1,2-b]isoquinoline-6-carbonitrile

References

1. Elena Montauti, et al. Sci Adv. 2022 Nov 25;8(47):eabo4116.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: